FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...

After months of searching for strategic options, Adaptimmune is offloading its cell therapies to a global pharma, which plans ...

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...

A spokesperson for the Department of Health and Human Services confirmed that Dr. Vinay Prasad, who led the FDA’s Center for ...

The FDA layoffs “will not affect drug, medical device, or food reviewers, nor will it impact inspectors,” a Health and Human Services fact sheet on the layoffs said.

Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...

Adaptimmune Therapeutics plans to drastically cut its workforce, including half of its C-suite, in conjunction with the sale ...

The Sarepta saga continues, with the FDA slapping a clinical hold across all of the company’s investigational limb-girdle ...

A leading food and health advisory agency has described the mass layoffs at the US Food and Drug Administration (FDA) as “devastating”. It emerged overnight that the Trump-appointed Secretary ...

This Massachusetts-based biopharmaceutical company announced hundreds of layoffs last week. Here's what the CEO said about it ...

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

The FDA layoffs “will not affect drug, medical device, or food reviewers, nor will it impact inspectors,” a Health and Human Services fact sheet on the layoffs said.